|
2.3141%
| US31572Q8087 | FGEN-US | FibroGen, Inc. |
1
|
|
1.8233%
| US19459J1043 | COLL-US | Collegium Pharmaceutical, Inc. |
2
|
|
1.8004%
| US2210061097 | CRVL-US | CorVel Corporation |
3
|
|
1.7216%
| US70975L1070 | PEN-US | Penumbra, Inc. |
4
|
|
1.7166%
| US6373722023 | NRC-US | National Research Corporation |
5
|
|
1.7137%
| US45168D1046 | IDXX-US | IDEXX Laboratories, Inc. |
6
|
|
1.7118%
| US4330001060 | HIMS-US | Oaktree Acquisition Corp Shs Cl A |
7
|
|
1.6555%
| US4364401012 | HOLX-US | Hologic, Inc. |
8
|
|
1.6106%
| US58506Q1094 | MEDP-US | Medpace Holdings, Inc. |
9
|
|
1.5763%
| US3795772082 | GMED-US | Globus Medical, Inc. Class A |
10
|
|
1.5468%
| US1167941087 | BRKR-US | Bruker Corporation |
11
|
|
1.5420%
| US4577301090 | INSP-US | Inspire Medical Systems, Inc. |
12
|
|
1.5223%
| US09061G1013 | BMRN-US | BioMarin Pharmaceutical Inc. |
13
|
|
1.5209%
| US4622221004 | IONS-US | Ionis Pharmaceuticals, Inc. |
14
|
|
1.5188%
| US8684591089 | SUPN-US | Supernus Pharmaceuticals, Inc. |
15
|
|
1.5180%
| US8064071025 | HSIC-US | Henry Schein, Inc. |
16
|
|
1.5152%
| US0028241000 | ABT-US | Abbott Laboratories |
17
|
|
1.5115%
| US5926881054 | MTD-US | Mettler-Toledo International Inc. |
18
|
|
1.4996%
| US6075251024 | MODN-US | Model N, Inc. |
19
|
|
1.4960%
| US7033951036 | PDCO-US | Patterson Companies, Inc. |
20
|
|
1.4945%
| US1011371077 | BSX-US | Boston Scientific Corporation |
21
|
|
1.4763%
| US03152W1099 | FOLD-US | Amicus Therapeutics, Inc. |
22
|
|
1.4491%
| US0352551081 | ANIK-US | Anika Therapeutics, Inc. |
23
|
|
1.4444%
| NL0012169213 | QGEN-US | QIAGEN NV |
24
|
|
1.4349%
| US2183521028 | CORT-US | Corcept Therapeutics Incorporated. |
25
|
|
1.4308%
| US5898891040 | MMSI-US | Merit Medical Systems, Inc. |
26
|
|
1.4305%
| US9418481035 | WAT-US | Waters Corporation |
27
|
|
1.4302%
| US8036071004 | SRPT-US | Sarepta Therapeutics, Inc. |
28
|
|
1.4297%
| US7611521078 | RMD-US | ResMed Inc. |
29
|
|
1.4286%
| US75886F1075 | REGN-US | Regeneron Pharmaceuticals, Inc. |
30
|
|
1.4252%
| US00846U1016 | A-US | Agilent Technologies, Inc. |
31
|
|
1.4214%
| US0067391062 | ADUS-US | Addus HomeCare Corporation |
32
|
|
1.4145%
| US09062X1037 | BIIB-US | Biogen Inc. |
33
|
|
1.4122%
| US74112D1019 | PBH-US | Prestige Consumer Healthcare Inc |
34
|
|
1.4033%
| US42222N1037 | HSTM-US | HealthStream, Inc. |
35
|
|
1.4019%
| US4050241003 | HAE-US | Haemonetics Corporation |
36
|
|
1.4008%
| US65343C1027 | NXGN-US | NextGen Healthcare, Inc. |
37
|
|
1.3998%
| US82710M1009 | SILK-US | Silk Road Medical, Inc. |
38
|
|
1.3908%
| US14149Y1082 | CAH-US | Cardinal Health, Inc. |
39
|
|
1.3899%
| US3755581036 | GILD-US | Gilead Sciences, Inc. |
40
|
|
1.3887%
| US74834L1008 | DGX-US | Quest Diagnostics Incorporated |
41
|
|
1.3836%
| US29358P1012 | ENSG-US | Ensign Group, Inc. |
42
|
|
1.3777%
| US92532F1003 | VRTX-US | Vertex Pharmaceuticals Incorporated |
43
|
|
1.3727%
| US16359R1032 | CHE-US | Chemed Corporation |
44
|
|
1.3666%
| US14888U1016 | CPRX-US | Catalyst Pharmaceuticals, Inc. |
45
|
|
1.3662%
| US45337C1027 | INCY-US | Incyte Corporation |
46
|
|
1.3551%
| US60770K1079 | MRNA-US | Moderna, Inc. |
47
|
|
1.3466%
| US89455T1097 | TMCI-US | Treace Medical Concepts, Inc. |
48
|
|
1.3458%
| US45784P1012 | PODD-US | Insulet Corporation |
49
|
|
1.3392%
| US46120E6023 | ISRG-US | Intuitive Surgical, Inc. |
50
|
|
1.3375%
| US58155Q1031 | MCK-US | McKesson Corporation |
51
|
|
1.3221%
| US1101221083 | BMY-US | Bristol-Myers Squibb Company |
52
|
|
1.3169%
| US2521311074 | DXCM-US | DexCom, Inc. |
53
|
|
1.3084%
| US91307C1027 | UTHR-US | United Therapeutics Corporation |
54
|
|
1.3078%
| US4781601046 | JNJ-US | Johnson & Johnson |
55
|
|
1.3071%
| BMG5269C1010 | KNSA-US | Kiniksa Pharmaceuticals Ltd. Class A |
56
|
|
1.3063%
| US98986M1036 | ZYXI-US | Zynex, Inc. |
57
|
|
1.3056%
| US03073E1055 | ABC-US | AmerisourceBergen Corporation |
58
|
|
1.2966%
| US2274831047 | CCRN-US | Cross Country Healthcare, Inc. |
59
|
|
1.2949%
| US5324571083 | LLY-US | Eli Lilly and Company |
60
|
|
1.2708%
| US4474621020 | HURN-US | Huron Consulting Group Inc. |
61
|
|
1.2690%
| US40637H1095 | HALO-US | Halozyme Therapeutics, Inc. |
62
|
|
1.2443%
| US00287Y1091 | ABBV-US | AbbVie, Inc. |
63
|
|
1.2303%
| US7170811035 | PFE-US | Pfizer Inc. |
64
|
|
1.2116%
| US64125C1099 | NBIX-US | Neurocrine Biosciences, Inc. |
65
|
|
1.2108%
| US0311621009 | AMGN-US | Amgen Inc. |
66
|
|
1.1693%
| US4131971040 | HRMY-US | Harmony Biosciences Holdings, Inc. |
67
|
|
1.1682%
| US0017441017 | AMN-US | AMN Healthcare Services, Inc. |
68
|
|
1.1472%
| US82489T1043 | SWAV-US | Shockwave Medical, Inc. |
69
|
|
0.9890%
| US9216591084 | VNDA-US | Vanda Pharmaceuticals Inc. |
70
|
